JHEP Reports · 2019 · 28 citations · 19 references
MedicineNutritionNutritional SciencesSarcopeniaTransplant PharmacotherapyTransplant SurgeryCirrhosisLiver DiseaseLiver TransplantationNutrition SupportNutritional SupportVasopressor TherapyContinuous Infusion PharmacologyHepatorenal Syndrome PharmacotherapyManagement Of Hepatorenal SyndromePost-transplant NutritionProtein Intake RegulationRefractory Ascites ManagementTransplant NutritionVasopressin Therapy
BACKGROUND & AIMS: Portal hypertension contributes to the pathogenesis of malnutrition and sarcopenia in cirrhosis via multiple mechanisms. Terlipressin is a vasopressin analogue that we administer via continuous outpatient infusion, as a bridge to transplantation in patients with hepatorenal syndrome or refractory ascites. We describe, for the first time, the impact of outpatient terlipressin on nutritional and muscle parameters. METHODS: Nutrition (subjective global assessment), handgrip strength, dietary intake (energy, protein), frequency of paracentesis and severity of liver disease (model for end-stage liver disease score) were prospectively recorded at terlipressin commencement and follow-up (transplantation, cessation or census date). RESULTS: = 0.001). CONCLUSION: Continuous terlipressin infusion reduces the complications of portal hypertension and is associated with an improvement in nutritional and muscle parameters in patients on the liver transplant waiting list, in whom such characteristics usually demonstrate progressive decline. This validates both the aetiological role of portal hypertension in malnutrition and represents a promising new anabolic therapy. LAY SUMMARY: Malnutrition and poor muscle strength are common in liver disease and often get worse while patients await liver transplant. Terlipressin is a medication used to treat portal hypertension in patients with hepatorenal syndrome. It is usually given for a few days or weeks in patients confined to hospital. Our centre provides outpatient terlipressin for weeks to months as a bridge to liver transplant. In patients treated with terlipressin at our hospital, we observed a substantial increase in their dietary intake and muscle strength, which may improve their quality of life and outcomes after liver transplant.
19
Sarcopenia: European consensus on definition and diagnosis
Alfonso J. Cruz‐Jentoft, Jean‐Pierre Baeyens, Jürgen M. Bauer et al. · Age and Ageing · 2010 · 11.7K citations · Full text
What is subjective global assessment of nutritional status?
AS Detsky, McLaughlin, JP Baker et al. · Journal of Parenteral and Enteral Nutrition · 1987 · 3.2K citations
Agriculture, Nutrition, Surgery +16
ESPEN Guidelines on Enteral Nutrition: Liver disease
Mathias Plauth, Eduard Cabré, Oliviero Riggio et al. · Clinical Nutrition · 2006 · 683 citations · Full text